In-person tickets are SOLD OUT. Join waitlist.
We invite colleagues from our member organisations to attend the 2024 BioMelbourne Network annual general meeting and networking event on Thursday 21 November.For our guests attending in person, the AGM will provide an opportunity to hear from a guest speaker, Dr Anna Lavelle AM, Non Executive Director.We look forward to seeing you on Thursday 21 November to reflect on the achievements of the previous year and explore our plans for the future.This is a free-to-attend event, available for BioMelbourne Network members only.Check our member directory.
AGM details:
Date: Thursday 21 November 2024
Time (AEDT):
4:00 – 4:45 pm: Formal AGM proceedings
4:45 – 6:15 pm: Guest speaker and networking
Format: In-person only
Venue: Tower Two, Collins Square 727 Collins Street, Docklands Victoria 3008
Kindly hosted by KPMG
Dr Anna Lavelle AM, Non Executive Director
Dr Anna Lavelle AM is an experienced Non – Executive Director serving for over 28 years on
the boards of not for profit, government and for profit entities. As Executive Director or Non Executive Director she has a deep and lengthy track record in healthcare delivery, technology development, negotiating policy/legislative outcomes and governance.
Anna has a PhD in Genetics from the University of Melbourne and is a Graduate of the Australian Institute of Company Directors (GAICD). Anna is a Fellow of the Academy of Technology Science and Engineering (FTSE) and is also a Fellow of the Leadership Victoria Program. In 2015 Nature Scientific America, World View ranked Anna in the global top 100 “World Visionaries” in biotechnology. Anna was the only Australian to be named.
In 2023 Anna was awarded an AM and admitted to the Order of Australia for services to innovation and science.
From 2005 to 2016, Anna was the CEO of AusBiotech; the national industry association for the biotechnology, pharmaceutical and medical devices sectors. Anna is now serving on several boards outlined below:
Current Governance Roles
2024 - Present, Non Executive Director, Omico.
2021 - Present, Non Executive Director, Island Pharmacueticals Ltd.
2020 - Present, Non Executive Director, Cyban Pty Ltd
2019 - Present, Non Executive Director, Hemideina Pty Ltd
2018 - Present, Independent Chair, Medicines Australia Ltd (reappointed for three years 2023-2026)
2018 - Present, Independent Chair, Avatar Brokers Pty Ltd
2023- Present, Innovation and Enterprise Advisory Board University of Melbourne Department of Medicine - Chaired by The Hon Greg Hunt